Log in to save to my catalogue

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disea...

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disea...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68883157

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

About this item

Full title

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

Publisher

London: Elsevier Ltd

Journal title

The Lancet (British edition), 2005-12, Vol.366 (9502), p.2012-2018

Language

English

Formats

Publication information

Publisher

London: Elsevier Ltd

More information

Scope and Contents

Contents

RTS,S/AS02A is a pre-erythrocytic stage malaria vaccine that provides partial protection against infection in malaria-naive adult volunteers and hyperimmune adults. A previous report showed that this vaccine reduced risk of clinical malaria, delayed time to new infection, and reduced episodes of severe malaria over 6 months in African children. An...

Alternative Titles

Full title

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_68883157

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68883157

Other Identifiers

ISSN

0140-6736,0099-5355

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(05)67669-6

How to access this item